The biotechnology company posted revenue of $5.9 million in the period. Alector shares have dropped 29% since the beginning of the year.
News
- Alector: 3Q Earnings Snapshot
- Histogen: 3Q Earnings Snapshot
The biotechnology company posted revenue of $495,000 in the period. In the final minutes of trading on Tuesday, the company's shares hit $1.75.
- Texas Physician Named to President-elect Joe Biden's Coronavirus Task Force
Immunologist, virologist. Ousted as head of the Biomedical Advanced Research and Development Authority after criticizing the federal government's ...
- bioAffinity Technologies to Present at 2020 American Society of Cell Biology Meeting
SAN ANTONIO--(BUSINESS WIRE)--bioAffinity Technologies, a privately held biotech company, today announced that its poster “Meso-tetra ...
- Why we didn't get a vaccine by Election Day - but why we may get one soon
Pfizer, Moderna and AstraZeneca are the front-runners. New York-based Pfizer, in partnership with the German biotech company BioNTech, announced ...